Inhibition of heregulin mediated MCF-7 breast cancer cell growth by the ErbB3 binding protein EBP1.
about
A computational strategy to select optimized protein targets for drug development toward the control of cancer diseasesAlterations in cell growth and signaling in ErbB3 binding protein-1 (Ebp1) deficient miceNovel snail1 target proteins in human colon cancer identified by proteomic analysis.Proteomic analysis identifies differentially expressed proteins after HDAC vorinostat and EGFR inhibitor gefitinib treatments in Hep-2 cancer cells.Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell lines.Regulation of tamoxifen sensitivity by a PAK1-EBP1 signalling pathway in breast cancer.The ErbB3 binding protein EBP1 regulates ErbB2 protein levels and tamoxifen sensitivity in breast cancer cellsP42 Ebp1 regulates the proteasomal degradation of the p85 regulatory subunit of PI3K by recruiting a chaperone-E3 ligase complex HSP70/CHIP.Transfer-RNA-mediated enhancement of ribosomal proteins S6 kinases signalling for cell proliferation.EBP1 protein modulates the expression of human MHC class II molecules in non-hematopoietic cancer cells.The ErbB3-binding protein EBP1 modulates lapatinib sensitivity in prostate cancer cells.The downregulation of ErbB3 binding protein 1 (EBP1) is associated with poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.ErbB3-binding protein EBP1 decreases ErbB2 levels via a transcriptional mechanism.Influenza virus infection induces cellular Ebp1 gene expression.Quantitative proteomics analysis of BMS-214662 effects on CD34 positive cells from chronic myeloid leukaemia patients.P7 peptides suppress the proliferation of K562 cells induced by basic fibroblast growth factor.Indolizine-Based Scaffolds as Efficient and Versatile Tools: Application to the Synthesis of Biotin-Tagged Antiangiogenic Drugs.
P2860
Q28543105-2C723CDA-8B78-424F-96E7-24AE89857479Q33394396-C2BE652B-21AD-4CEE-867F-A9BF89670AD3Q33565347-5B026DB1-36E4-439A-83C6-507F3080918AQ33962243-502DE3F1-E4A9-4DA8-BA75-00981A9B930BQ35551911-08595759-B3C8-4F34-ADF0-B90BD2C44CCBQ36671906-95AA88B0-316D-440B-9AA5-F8D862572867Q37006208-F5803587-E7B5-43CA-BF71-A99FFEEE976DQ37680192-9FE4988D-5E14-491A-BD5B-6BA9BFAF212FQ38399798-7C96E874-5F42-49BE-A8EF-E6EDEA6192B6Q38863174-6B2F604D-2821-4483-84A9-DFF6570A9B9AQ38886817-274A7C99-8C0E-4B7E-B092-B2EFDDBC7A9AQ38969791-E74B1761-88D1-4148-9743-F5E9E54D273BQ39225756-FEF29229-CF5C-4319-AD6F-9C48716E5D51Q39499978-82ADABA7-5D79-4FF2-94B1-476C23E2A78EQ46006972-0BFD1FDA-C238-42FB-A504-9073B66F5C11Q53184353-020D9B1F-F687-4A6E-A609-3AA2E671BF4CQ55687548-D9C4FF2E-D6BD-48EE-A575-8B5636384359
P2860
Inhibition of heregulin mediated MCF-7 breast cancer cell growth by the ErbB3 binding protein EBP1.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Inhibition of heregulin mediat ...... he ErbB3 binding protein EBP1.
@en
type
label
Inhibition of heregulin mediat ...... he ErbB3 binding protein EBP1.
@en
prefLabel
Inhibition of heregulin mediat ...... he ErbB3 binding protein EBP1.
@en
P2093
P2860
P1433
P1476
Inhibition of heregulin mediat ...... he ErbB3 binding protein EBP1.
@en
P2093
Anne W Hamburger
Damilola Akinmade
Yuexing Zhang
P2860
P304
P356
10.1016/J.CANLET.2008.02.024
P407
P577
2008-03-19T00:00:00Z